Abstract:Objective: We conducted this scoping review to map and summarize scientific evidence on the role of clinical pharmacists in the palliative care of adults and elderly patients with cancer. Data Sources: A literature search was performed in MEDLINE, PubMed Central, Embase, Web of Science, Scopus, and BVS/BIREME for studies published until November 22nd, 2020. Studies that reported work experiences adopted by clinical pharmacists in the palliative care of adults and elderly patients with cancer were included. Two… Show more
“…Today community pharmacists [ 27 – 30 ], capable and trained to treat patients at a personal level, as well as hospital [ 31 – 34 ] pharmacists are quite late involved in palliative care management practiced for many centuries (Fig. 1 ).…”
The World Health Organization supports early delivery of palliative care as it reduces unnecessary hospital admissions and the inappropriate use of health care services. A community pharmacist can play a key role in advocating timely access to palliative care. Medication reconciliation must alert them to start communicating with the patient and/or his relatives about refocusing treatment and care as part of palliative and terminal care. Pharmaceutical activities for these patients include dispensing of devices and medicinal products, compounding personalized medication and participating as a member of the Palliative Support Team. Most of the several thousands of rare diseases are caused by genetic defects and up to now have no cure and a late diagnosis.
“…Today community pharmacists [ 27 – 30 ], capable and trained to treat patients at a personal level, as well as hospital [ 31 – 34 ] pharmacists are quite late involved in palliative care management practiced for many centuries (Fig. 1 ).…”
The World Health Organization supports early delivery of palliative care as it reduces unnecessary hospital admissions and the inappropriate use of health care services. A community pharmacist can play a key role in advocating timely access to palliative care. Medication reconciliation must alert them to start communicating with the patient and/or his relatives about refocusing treatment and care as part of palliative and terminal care. Pharmaceutical activities for these patients include dispensing of devices and medicinal products, compounding personalized medication and participating as a member of the Palliative Support Team. Most of the several thousands of rare diseases are caused by genetic defects and up to now have no cure and a late diagnosis.
“…Pharmacists are essential to addressing and managing medicines-related issues, and educating and supporting patients and/or their carers. 38,39 Palliative care pharmacists, ideally embedded within palliative care interdisciplinary teams, demonstrate competence in palliative care and the ability to integrate medicines expertise with holistic care. Palliative care pharmacists who do not work in an embedded role (non-specialist palliative care settings) can be supported by being given access to advice from palliative care pharmacists and other members of palliative care interdisciplinary teams who do work in specialist palliative care settings.…”
The authors acknowledge the Traditional Custodians of the lands on which our members meet, work, and live, including the Wurundjeri people of the Kulin Nation, Traditional Custodians of Naarm where the Society of Hospital Pharmacists of Australia (SHPA) is based. We thank Elders past and present, and celebrate Aboriginal and Torres Strait Islander Peoples as the first pharmacists, bush medicine practitioners, and doctors who practised on these lands.
“…A European whitepaper on standards and norms for HPC lists pharmacists as members of the multiprofessional team in the provision of PC services, yet fails to define their roles [ 25 ]. The COVID-19 situation contributed efforts to further develop the role of pharmacists in HPC [ 26 ] and pharmacy services in patients with advanced cancer are increasingly implemented [ 27 ]. However, the scope of HPC is much broader.…”
Background
Pharmacists contribute to medication safety by providing their services in various settings. However, standardized definitions of the role of pharmacists in hospice and palliative care (HPC) are lacking.
Aim
The purpose of this scoping review was to provide an overview of the evidence on the role of pharmacists and to map clinical activities in inpatient HPC.
Method
We performed a scoping review according to the PRISMA-ScR extension in CINAHL, Embase, and PubMed. We used the American Society of Hospital Pharmacists (ASHP) Guidelines on the Pharmacist’s Role in Palliative and Hospice Care as a framework for standardized categorization of the identified roles and clinical activities.
Results
After screening 635 records (published after January 1st, 2000), the scoping review yielded 23 publications reporting various pharmacy services in HPC. The articles addressed the five main categories in the following descending order: ‘Medication order review and reconciliation’, ‘Medication counseling, education and training’, ‘Administrative Roles’, ‘Direct patient care’, and ‘Education and scholarship’. A total of 172 entries were mapped to the subcategories that were added to the main categories.
Conclusion
This scoping review identified a variety of pharmacists’ roles and clinical activities. The gathered evidence will help to establish and define the role of pharmacists in inpatient hospice and palliative care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.